T. Rowe Price Associates’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$194M Buy
1,125,143
+1,052,287
+1,444% +$195M 0.02% 468
2025
Q4
$14.5M Hold
72,856
﹤0.01% 1145
2025
Q3
$11.4M Sell
72,856
-1,614
-2% -$256K ﹤0.01% 1196
2025
Q2
$11.3M Sell
74,470
-1,498
-2% -$200K ﹤0.01% 1089
2025
Q1
$11.4M Sell
75,968
-95,251
-56% -$16M ﹤0.01% 1086
2024
Q4
$31.6M Sell
171,219
-1,687
-1% -$325K ﹤0.01% 882
2024
Q3
$34.1M Sell
172,906
-468,079
-73% -$97.3M ﹤0.01% 862
2024
Q2
$132M Sell
640,985
-681,469
-52% -$154M 0.02% 484
2024
Q1
$358M Sell
1,322,454
-120,721
-8% -$28.8M 0.04% 325
2023
Q4
$341M Sell
1,443,175
-237,498
-14% -$46.7M 0.05% 318
2023
Q3
$329M Sell
1,680,673
-815,821
-33% -$167M 0.05% 303
2023
Q2
$525M Sell
2,496,494
-9,799
-0.4% -$1.95M 0.07% 243
2023
Q1
$506M Buy
2,506,293
+653,790
+35% +$148M 0.08% 239
2022
Q4
$404M Buy
1,852,503
+266,004
+17% +$58.1M 0.06% 267
2022
Q3
$312M Buy
1,586,499
+482,207
+44% +$104M 0.05% 294
2022
Q2
$236M Buy
1,104,292
+883,029
+399% +$216M 0.03% 436
2022
Q1
$62.8M Buy
221,263
+1,892
+0.9% +$583K 0.01% 890
2021
Q4
$82.7M Sell
219,371
-2,413
-1% -$937K 0.01% 828
2021
Q3
$91.5M Sell
221,784
-65,081
-23% -$27M 0.01% 797
2021
Q2
$106M Buy
286,865
+39,642
+16% +$13.2M 0.01% 762
2021
Q1
$71.7M Sell
247,223
-19,630
-7% -$5.46M 0.01% 875
2020
Q4
$66.7M Sell
266,853
-18,600
-7% -$4.43M 0.01% 858
2020
Q3
$64.6M Sell
285,453
-112,229
-28% -$23.3M 0.01% 790
2020
Q2
$69.3M Sell
397,682
-207,395
-34% -$33.1M 0.01% 741
2020
Q1
$76.4M Buy
605,077
+15,868
+3% +$2.38M 0.01% 653
2019
Q4
$90M Buy
589,209
+17,323
+3% +$2.4M 0.01% 697
2019
Q3
$75.7M Buy
571,886
+17,783
+3% +$2.38M 0.01% 718
2019
Q2
$78.6M Sell
554,103
-1,382
-0.2% -$187K 0.01% 716
2019
Q1
$80.7M Sell
555,485
-191
-0% -$25.1K 0.01% 700
2018
Q4
$62.9M Buy
555,676
+8,236
+2% +$1.03M 0.01% 737
2018
Q3
$73.7M Buy
547,440
+45,839
+9% +$5.66M 0.01% 771
2018
Q2
$56.3M Buy
501,601
+53,525
+12% +$5.79M 0.01% 847
2018
Q1
$47.8M Buy
448,076
+14,852
+3% +$1.6M 0.01% 896
2017
Q4
$47.4M Buy
433,224
+38,712
+10% +$4.21M 0.01% 888
2017
Q3
$42.6M Buy
394,512
+40,174
+11% +$4.13M 0.01% 912
2017
Q2
$35.8M Buy
354,338
+16,928
+5% +$1.56M 0.01% 954
2017
Q1
$30.4M Buy
337,410
+40,803
+14% +$3.47M 0.01% 992
2016
Q4
$22.6M Sell
296,607
-5,677
-2% -$431K ﹤0.01% 1097
2016
Q3
$25.2M Buy
302,284
+16,970
+6% +$1.42M 0.01% 1050
2016
Q2
$23.5M Buy
285,314
+88,189
+45% +$7.26M 0.01% 1046
2016
Q1
$15M Buy
197,125
+182,732
+1,270% +$13.5M ﹤0.01% 1172
2015
Q4
$1.16M Sell
14,393
-5,349
-27% -$386K ﹤0.01% 1650
2015
Q3
$1.25M Buy
19,742
+211
+1% +$15.2K ﹤0.01% 1646
2015
Q2
$1.37M Buy
19,531
+5,130
+36% +$380K ﹤0.01% 1665
2015
Q1
$1.14M Buy
14,401
+74
+0.5% +$5.46K ﹤0.01% 1697
2014
Q4
$912K Buy
14,327
+266
+2% +$16.7K ﹤0.01% 1749
2014
Q3
$840K Buy
14,061
+1,405
+11% +$80.4K ﹤0.01% 1777
2014
Q2
$677K Sell
12,656
-904
-7% -$49.6K ﹤0.01% 1836
2014
Q1
$818K Buy
13,560
+1,992
+17% +$116K ﹤0.01% 1743
2013
Q4
$614K Sell
11,568
-6,600
-36% -$331K ﹤0.01% 1823
2013
Q3
$840K Sell
18,168
-2,400
-12% -$110K ﹤0.01% 1716
2013
Q2
$844K Buy
+20,568
New +$881K ﹤0.01% 1704

Other funds holding CRL